chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had normal flu-like symptoms about 12 hours after the vaccine. I experienced brain fog and joint pain and fatigue that continued after the initial few days. My knees and hip joints were the worst. About a month after the vaccine my elbows were also stiff. The joint pain was compounding to different areas. I tried anti-inflammatory medications, but they did not work. I tried some cleanses for inflammation and those help as long as I repeat the process. I had never had joint pain before. The doctor recommended the anti-inflammatory medications, so I tried the cleanse. The brain fog has also continued. I have trouble articulating what I want to say as well as what I need to write down. I had brain fog since I had COVID-19 in 2020 but it seemed to get worse after the vaccine. My energy level also seems less than before the vaccine. I got COVID-19 in November of 2020 and then again since I was vaccinated in January of 2022. My post vaccination COVID-19 infection started with aches and pain with extreme tiredness. My eyes burned and I had an extreme headache. I also cough when I take a deep breath and it has been almost two months. The coughing started in the first few days, and it was a shallow tickling cough. I had headaches for 3-4 days and then I still got them occasionally and they started in my eyes. My worst symptoms lasted to be a week. The brain fog was a little worse during my infection and has still lingered.
Patient's arm is red and inflamed. Patient is not worried and will monitor for worsening symptoms.
Information has been received from a registered nurse concerning a 4 year old female who was vaccinated on 12/08/2000 with a dose of varicella virus vaccine live (Oka/Merck).  The patient was seen on 06/12/2003 with a chickenpox breakthrough, described as a rash on her body for 2 days.  No therapy was required.  The outcome was reported as recovered.  Unspecified medical attention was sought.  There was no product quality complaint.  The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and developed chickenpox breakthrough/shingles.  No further information is expected.
erythema, ecchymosis, pain & edeam @ inject site are reported in a pt who recvd 1 dose of flu vax; above occurred 12 hrs p/flu vax given & resolved w/in 48 hrs;
left under aspect of arm approx 7 im 1-2cm scabbed marks on arm. Say this was noted 3 days after receiving hep B. No swelling noted. Minimal redness. Child said itches. Pt had not seen PMD. Referred to PMD.
Pt c/o coughing and SOB   pt states he received 1st dose of covid vaccine on the 01/22/21 presented to the ED with fever, chills and shortness of  breath. He tested positive for covid. In the ED he was hypoxic to 87% on RA.   # Hypoxic respiratory failure: 2/2 covid pna. Room air sats 87%, up to 92% on 4L  # COVID pneumonia: no suspicion for bacterial etiology.   REMDESIVIR administration started on 1/25/21. Transferred to Hospital, (2/3/21)  for higher level    of care Intubated COVID 19.
Heart Palpitation; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart Palpitation) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (had COVID-19 prior to the vaccine). Concurrent medical conditions included Muscle pain (Still experiencing the muscle pain even after having COVID).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PALPITATIONS (Heart Palpitation). The patient was treated with DIAZEPAM (VALIUM) at a dose of 4 mg; OLMESARTAN MEDOXOMIL (BENICAR) at a dose of 20 mg and METOPROLOL SUCCINATE (TOPROL) at a dose of 25 mg. At the time of the report, PALPITATIONS (Heart Palpitation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant medication history included Blood pressure medications. No relevant concomitant medications reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Significant follow up added.Reporters contact information updated, Patients Historical condition and current condition added
pt recv vax DEC94 & pt exp moderate to severe varicella w/over 200 lesions;
Hair loss,it has gotten worse; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair loss,it has gotten worse) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Depression and Anxiety. Concomitant products included BUSPIRONE HYDROCHLORIDE (BUSPAR) for Anxiety, VILAZODONE HYDROCHLORIDE (VIIBRYD) for Depression, LEVOTHYROXINE SODIUM (SYNTHROID) and ZOLPIDEM for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced ALOPECIA (Hair loss,it has gotten worse). At the time of the report, ALOPECIA (Hair loss,it has gotten worse) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) A blood test came out fine..         The concomitant medication used for depression and anxiety. Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Streaks on R arm one day post vaccine.  General lethargy and seen by Dr. on 2/2/06 at 7pm.  Received hydrocortisone shot and Augmentin
This spontaneous report was received from medical assistant and from an employee from the same reporting institution, referring to a patient of unknown age and gender. The patient's medical history, drug reactions/allergies and concomitant medications were not provided. On 18-DEC-2017, the patient was vaccinated with one improperly stored dose of LIQUID PEDVAXHIB (lot # N027768, expiry date: 03-OCT-2019), for prophylaxis (dose and route of administration were not reported). The vaccine underwent a temperature from 47 Fahrenheit degrees (°F) to 77 °F by a time frame of 48 hours and 20 minutes, with no previous temperature excursion and with digital data logger involved, as reported by the medical assistant on 18-DEC-2017. On 27-DEC-2017, the employee reported that after further investigation it was determined they were in the safe range for up 72 hours, so it was not considered improperly stored.
Narrative: Patient reported nausea following seconding dose of Pfizer COVID vaccine. Patient required no intervention, was in no acute distress, and was well enough to drive home.
After completion of series, 2 weeks following 2nd dose, client tested positive for Covid-19 by PCR (positive on 2/4/2021)
Sever Dry cough, congestion, nausea, trouble breathing, shortness of breath, chest pain.
pain at injection site; body aches; mild headache; This is a spontaneous report from a contactable nurse (patient herself). A 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL0142; expiry date: unknown) via an unspecified route of administration, on 04Jan2021, at 0.3 mL, single for COVID-19 immunization. Patient has no relevant medical history. Concomitant medications were not reported. Prior to taking vaccine, she did an antibody test and it was positive for antibodies s in Nov2020, she remembered that she went for a complete physical. All COVID tests were negative but the antibody test was positive. She did a rapid test a week before the vaccine at the end Dec2020. The PCR Test was a couple months before the vaccine in Apr2020 and it was negative. During that time in Apr2020 she had mild symptoms and was not feeling well but then she felt better. The doctor gave her azithromycin and vitamins, a week later she was better. At her job they were doing COVID test every 2 weeks, but she was negative. She had no more symptoms. She has had no issues with vaccines in the past. She would get unspecified flu shots at work  for flu vaccination, but would get mild pain at the injection site. Patient received PFIZER-BIONTECH COVID-19 VACCINE on 04Jan2021 and had been experiencing pain at injection site, mild body aches, and mild headaches. Her 1st dose was on 04Jan2021 at 4 o clock. The pain at injection site began on 05Jan2021. The body aches and headache also started on 05Jan2021, but she noticed relief with Tylenol. She has called her physician since she does not want to go in office. Her symptoms were ordinary and mild but bothersome, she doesn't know with this vaccine and what she would be feeling and decided on staying home. The pain at injection site stopped sometime between yesterday and today. Her 2nd dose is scheduled on 25Jan2021. Outcome of the event pain at injection site was recovered on an unspecified date in Jan2021, while for the remaining events was recovering.
death Focal seizure Subdural bleeding Acute kidney failure, unspecified Unspecified convulsions
I have tinging and numbness on my right hand since 21May. It especially get worse at night where the tingling is severe; I have tinging and numbness on my right hand since 21May. It especially get worse at night where the tingling is severe; Changes in menstrual cycle- I have tinging and numbness on my right hand since 21May. It especially get worse at night where the tingling is severe; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09May2021 15:00 (Lot number: EK8429) at the age of 33 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious), HYPOAESTHESIA (non-serious) all with onset 21May2021, outcome "not recovered" and all described as "I have tinging and numbness on my right hand since 21May. It especially get worse at night where the tingling is severe"; MENSTRUAL DISORDER (non-serious) with onset 21May2021, outcome "not recovered", described as "Changes in menstrual cycle- I have tinging and numbness on my right hand since 21May. It especially get worse at night where the tingling is severe". Therapeutic measures were not taken as a result of paraesthesia, hypoaesthesia, menstrual disorder.  Additional Information: Hospitalization Prolonged was reported as no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not received any other medication within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. The other medical history was reported as no.  Follow-up attempts are completed. No further information is expected.
she started to feel "pick, pick, pick" starting in the ears; This is a spontaneous report from a contactable other healthcare professional (patient).  A female patient of an unspecified age (Age: 67; Units: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 30Dec2020 16:20 to 30Dec2020 16:20 as single dose for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient reported she received the vaccine on 30Dec2020 16:20 and four hours post administration she started to feel 'pick, pick, pick' starting in the ears. The outcome of the event was unknown.  Information about Lot/batch no has been requested.
Localized redness and swelling at the site of injection 2 x 2 cm in diameter. Raised given BENADRYL in office observed for 1 hr. (L) leg MMR/Varicella.
C/O pruritic rash to abd & polyarthralgias, pain & tenderness at inj site, massefe, muscles tight per pt
Upper chest pain, heartache, high heartbeat. No treament. The symptoms go away in 1 - 2 hours.
Volunteer administered this vaccine to a 17-year-old (although per document review, this patient had received first dose of Moderna at a different site on 3/26/2021)
Patient received hep b dose 1 on 9/27/22, patient states on 9/28/22 her lips began having "muscle spasms and twitching involuntarily", the twitching continued for 2 days and ended on 9/29/22, on 9/30/22 the patient states " My right palm was extremely itchy and had a red warm bump on it", all symptoms have since resolved
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 26-MAR-2013, the patient was vaccinated with a dose of improperly stored PROQUAD (Lot number as H020140, expiry date was 07-MAY-2014, route and dose were not reported) at around 9 am. No adverse effect was reported. Follow up information was received from the medical assistant regarding the 5 year old male patient. Reporter details and patient details were updated. Patient's birth weight was reported as 38 (units unknown). The patient received the improperly stored dose of (Merck) PROQUAD subcutaneously on 26-MAR-2013 08:30 AM. This is one of the three reports received from the same reporter. Additional information is not expected.
Information has been received from a registered nurse referring to a patient of unknown age and gender on 20-OCT-2017. There was no information about patient's concurrent conditions, medical history or concomitant medications. On 16-OCT-2017, the patient was vaccinated with improperly stored VARIVAX lot # N012131 and expiration date of 17-APR-2019, (route of administration and anatomical location were not reported) for prophylaxis, reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT) (lot # unknown), The vaccines were stored in the range of 6 Farenheit degrees to 14 Farenheit degrees for 3 hours and 40 minutes. No previous temperature excursion was reported. The patient did not experience any adverse events. igital data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1709USA007342: US-009507513-1710USA014743: US-009507513-1710USA014744: US-009507513-1710USA014745: US-009507513-1710USA014746: US-009507513-1710USA014747: US-009507513-1710USA014748:
Large local reaction - redness, swelling. Took BENADRYL - agitation, rage, headache, pupils unequal, low LOC.
4:00 PM After administration of Flu Mist, member reported upper lip swelling and tingling.
About 12 hours after I received the bivalent booster, around three in the morning, I was awakened with pain in my left thumb I believe, my two wrists, and especially my right elbow. After a day the pain or inflammation in my thumb and wrists went away but it has persisted in my right elbow. There may be one skin lesion, only the size of a pimple, at or very near the site. That has all but gone away. The pain is less now than it was in the beginning. It feels like ?tennis elbow? I have had joint pain with each of these Moderno Covid vaccinations and boosters. But not this sort of more intense inflammation sort of pain. More and achy joint pain like when I have a fever. But this is like an injury ? ? like I said ?tennis elbow? I also get a fever for a day or two. My symptoms in addition to this inflammation pain for the bivalent included a headache, fever of maybe 101, bodyaches, all of which resolved after 1 to 1 1/2 days except for the right elbow pain. My father suffered from severe rheumatoid arthritis but I have never had Anything like this until now.
SHINGLES VIRUS ON BACK; This spontaneous case was reported by an other health care professional and describes the occurrence of HERPES ZOSTER (SHINGLES VIRUS ON BACK) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included UPADACITINIB (RINVOQ) from 12-Apr-2021 to an unknown date for Rheumatoid arthritis.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced HERPES ZOSTER (SHINGLES VIRUS ON BACK). At the time of the report, HERPES ZOSTER (SHINGLES VIRUS ON BACK) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment information as not reported.
Fever, Diarrhea, NauseaVomiting & Tachycardia Narrative:
OUT OF SPECIFICATION PRODUCT USE; INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned an 18 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809 expiry: UNKNOWN) dose was not reported, administered on 13-APR-2022 for covid-19 prophylaxis. The drug was associated with Medication error. Age at time of vaccination 18 years old. No concomitant medications were reported. On 2022, the patient experienced incorrect product storage. On 13-APR-2022, the patient experienced out of specification product use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the out of specification product use and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20220759289, 20220759337, 20220759113, 20220759160, 20220759219 and 20220759222.
high fever, generalized red spots on body; sz; throat red; tx on ATB-hosp ER;
Starting 2 hours after vaccine, mild fever, severe fatigue, and severe joint, muscle, and skin pain lasting 36 hours. Tylenol 1000mg used every 6 hours provided only mild relief. After 36 hours mild fever is still present but pain is now mild to moderate and fatigue is moderate.
Patient reported feeling hot shortly after receiving her vaccine with an itchy arm. We provided and ice pack and laid her down on a stretcher. Patient became slightly erratic and we proceeded to wheel her down to ER. ER summary below.    ED Course:  Patient's pertinent past medical, social, family medical history were reviewed from both the nursing notes and the electronic medical record. This is a 27-year-old female with a past medical history as above presenting with a chief complaint of concern for urticarial rash in anaphylaxis following a COVID-19 vaccination.      I did speak with Occupational Health who stated that this patient is well-known to the hospital, stating specifically that she becomes very anxious with vaccinations/needles and breaks out in hives on previous injections.  This information was given to his after her initial presentation.  Patient had already been removed provided epinephrine given concern of possible anaphylactic reaction given her area, diaphoresis, pruritus and diffuse urticaria.   I was called into the room multiple times as patient continued to ask to be discharged.  I did have multiple conversations with her in regards to need for continued monitoring given possibility of anaphylactic reaction.  She feels that this was due to her anxiety and states that she is completely asymptomatic and at her baseline at this time.  She once again is asking to leave.  I did discuss my recommendation for continued monitoring as well as the risks of leaving without continued monitoring.   The patient is able to choose, communicate and make choices clearly and understandably. The patient is able to understand risks, benefits and alternatives of therapy explained by myself. The patient can make a logical and rational decisions according to my assessment. The choice made by the patient is consistent with the patient's values and is consistent with character and decision capacity in the patient's past, according to friends and family present. There is no impending medical risk to this patient to warrant my holding the patient against their will.   Patient will be discharged in stable condition at this time with strict return precautions and instructions for close outpatient follow-up.  She was provided EpiPen given possibility of anaphylactic reaction in the future.
Shoulder swollen, hard, big red hive (raised), hot, itchy and no pain or fever. Lasted 3 days.
I had a sore arm.  I started  getting weak (like a flu).  I had a fever. I had diarrheas and body ache   My symptoms keep gone for weeks.
I did not have an adverse reaction to the vaccine but I did contract COVID-19. Test positive on June 30.  I had a stuffy nose, congestion and a dry cough.  I went to see my doctor and he didn't think I needed a prescription. I took over-the-counter cold medication for my symptoms.
Patient had redness and pain at both injection sites. She went to urgent care and was treated with Bactrim ds and her symptoms improved